Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk of Breast Cancer”

723 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 723 results

Testing effectiveness (Phase 2)Enrolling By InvitationNCT06680596
What this trial is testing

Detecting Tumor DNA in the Blood of HR+/HER2-low Metastatic Breast Cancer Patients to Find Candidates for T-DXd Therapy

Who this might be right for
Breast Cancer MetastaticBreast Cancer Stage IV
UNICANCER 80
Not applicableLooking for participantsNCT06970288
What this trial is testing

Effectiveness of Introducing Ultra-High B-Value Diffusion-Weighted Imaging as a Modified Abbreviated Protocol for Breast Cancer Detection

Who this might be right for
Breast Carcinoma
Ain Shams University 85
Not applicableStudy completedNCT00255060
What this trial is testing

Comprehensive Screening for Women at High Genetic Risk for Developing Breast Cancer

Who this might be right for
Breast Cancer
Stanford University 100
Testing effectiveness (Phase 2)Looking for participantsNCT04787042
What this trial is testing

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

Who this might be right for
CancerSolid TumorMelanoma+6 more
Simcha IL-18, Inc. 316
Not applicableWithdrawnNCT01445275
What this trial is testing

Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199

Who this might be right for
Fallopian Tube CarcinomaHereditary Breast and Ovarian Cancer SyndromeOvarian Carcinoma+1 more
Gynecologic Oncology Group
Large-scale testing (Phase 3)Active Not RecruitingNCT05952557
What this trial is testing

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

Who this might be right for
Breast Cancer, Early Breast Cancer
AstraZeneca 5,511
Large-scale testing (Phase 3)UnknownNCT00402519
What this trial is testing

APBI Versus EBRT Therapy After Breast Conserving Surgery for Low-risk Breast Cancer

Who this might be right for
Breast Cancer
University of Erlangen-Nürnberg Medical School 1,300
Testing effectiveness (Phase 2)Study completedNCT00064311
What this trial is testing

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
National Institutes of Health Clinical Center (CC)
Large-scale testing (Phase 3)Study completedNCT01354522
What this trial is testing

TAC Versus TCX as Adjuvant Treatment for High-risk Her2-Negative Breast Cancer

Who this might be right for
Breast Cancer
Peking Union Medical College Hospital 204
Early research (Phase 1)Study completedNCT00976339
What this trial is testing

Study of Vitamin D for Premenopausal Women at High Risk for Breast Cancer

Who this might be right for
Breast Cancer
Katherine D. Crew 20
Early research (Phase 1)Study completedNCT02063724
What this trial is testing

HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 15
Testing effectiveness (Phase 2)Study completedNCT02229084
What this trial is testing

Vaccination of High Risk Breast Cancer Patients

Who this might be right for
Breast CancerBreast Neoplasms
University of Arkansas 58
Not applicableNot Yet RecruitingNCT06728150
What this trial is testing

Study Investigating the Role of Routine Screening and Molecular Characterisation of Brain Metastasis in the Management of High-risk Metastatic Breast Cancer

Who this might be right for
Breast Cancer MetastaticBrain Metastasases
Monash University 45
Very early researchWithdrawnNCT03473691
What this trial is testing

Pilot Study of Glembatumumab Vedotin Following Doxorubicin and Cytoxan as Neo-adjuvant Therapy in Gp-NMB-expressing High Risk Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
University of Virginia
Testing effectiveness (Phase 2)Ended earlyNCT00824538
What this trial is testing

Sunitinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Who Have Tumor Cells in the Bone Marrow

Who this might be right for
Breast Cancer
University of California, San Francisco 13
Not applicableStudy completedNCT02963740
What this trial is testing

Feasibility of High Levels of Energy Expenditure From Physical Activity for Breast Cancer Survivors

Who this might be right for
Breast Cancer Female
University of Kansas Medical Center 11
Not applicableStudy completedNCT00347568
What this trial is testing

BC-DAISY: A Breast Cancer Decision Aid System

Who this might be right for
Breast Cancer
Rhode Island Hospital 195
Large-scale testing (Phase 3)Looking for participantsNCT04261244
What this trial is testing

NeoRad Breast Cancer Study

Who this might be right for
Breast Cancer
Bielefeld University 1,826
Not applicableWithdrawnNCT00083044
What this trial is testing

Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy

Who this might be right for
Breast Cancer
Northwestern University
Large-scale testing (Phase 3)Looking for participantsNCT07019363
What this trial is testing

CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk, HR+/HER2+ Early Breast Cancer Patients(CHESS)

Who this might be right for
Breast CancerAdjuvant Therapy
Fudan University 1,903
Next Page